Analyze Diet
Journal of veterinary pharmacology and therapeutics2013; 37(1); 35-42; doi: 10.1111/jvp.12056

Effect of body weight on the pharmacokinetics of flunixin meglumine in miniature horses and quarter horses.

Abstract: In most species, large variations in body size necessitate dose adjustments based on an allometric function of body weight. Despite the substantial disparity in body size between miniature horses and light-breed horses, there are no studies investigating appropriate dosing of any veterinary drug in miniature horses. The purpose of this study was to determine whether miniature horses should receive a different dosage of flunixin meglumine than that used typically in light-breed horses. A standard dose of flunixin meglumine was administered intravenously to eight horses of each breed, and three-compartmental analysis was used to compare pharmacokinetic parameters between breed groups. The total body clearance of flunixin was 0.97 ± 0.30 mL/min/kg in miniature horses and 1.04 ± 0.27 mL/min/kg in quarter horses. There were no significant differences between miniature horses and quarter horses in total body clearance, the terminal elimination rate, area under the plasma concentration versus time curve, apparent volume of distribution at steady-state or the volume of the central compartment for flunixin (P > 0.05). Therefore, flunixin meglumine may be administered to miniature horses at the same dosage as is used in light-breed horses.
Publication Date: 2013-05-10 PubMed ID: 23659780DOI: 10.1111/jvp.12056Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Clinical Trial
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research concerns the effect of bodyweight on how the medication flunixin meglumine is processed in miniature horses compared to light-breed horses. The study found no noticeable differences between the two and thus suggests using the same dosage for both types of horses.

Study Purpose and Methodology

  • The study aimed to find out if miniature horses should be given different dosage of flunixin meglumine (a non-steroidal anti-inflammatory drug, NSAID, used in horses) compared to light-breed horses, such as quarter horses.
  • This is due to the large size disparity between these types of horses and the common practice of adjusting medication dosages based on bodyweight among different species.
  • The researchers conducted the experiment by injecting the standard dose of flunixin meglumine intravenously to eight horses from each breed. They used a three-compartmental analysis method to compare the pharmacokinetic parameters between the two groups.

Key Findings

  • The total body clearance of flunixin meglumine drug was found to be almost the same among miniature horses and quarter horses (0.97 ± 0.30 mL/min/kg and 1.04 ± 0.27 mL/min/kg, respectively).
  • The study did not find significant differences between the breeds in terms of total body clearance, terminal elimination rate (the rate at which the drug is expelled from the body), and the area under the plasma concentration versus time curve (a measure of the overall exposure of the body to the drug).
  • In addition, apparent volume of distribution at steady-state (the volume into which a drug would need to be evenly distributed to produce the observed blood concentration) and volume of the central compartment (volume in the body where the drug appears to stay) for flunixin were also similar between miniature and quarter horses.

Conclusion

  • The findings suggested that despite the size variation between miniature horses and light-breed horses, the same dosage of flunixin meglumine can be used for both breeds.
  • The researchers recommend that the current standard dosages used for light-breed horses can also be applied to miniature horses safely and effectively.

Cite This Article

APA
Lee CD, Maxwell LK. (2013). Effect of body weight on the pharmacokinetics of flunixin meglumine in miniature horses and quarter horses. J Vet Pharmacol Ther, 37(1), 35-42. https://doi.org/10.1111/jvp.12056

Publication

ISSN: 1365-2885
NlmUniqueID: 7910920
Country: England
Language: English
Volume: 37
Issue: 1
Pages: 35-42

Researcher Affiliations

Lee, C D
  • Department of Clinical Sciences, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK, USA.
Maxwell, L K

    MeSH Terms

    • Animals
    • Anti-Inflammatory Agents, Non-Steroidal / pharmacokinetics
    • Body Weight / physiology
    • Clonixin / analogs & derivatives
    • Clonixin / pharmacokinetics
    • Female
    • Horses / blood
    • Horses / physiology
    • Male

    Citations

    This article has been cited 4 times.
    1. Kuroda T, Knych HK, Noble GK, Minamijima Y, Leung GN, Nomura M, Mizobe F, Ishikawa Y, Kusano K, Toutain PL. A Meta-Analysis of International Flunixin Pharmacokinetics in Horses: Toward Regulatory Harmonization and Individualized Detection Times Using Bayesian Paradigm. Drug Test Anal 2026 Jan;18(1):32-50.
      doi: 10.1002/dta.3961pubmed: 41137541google scholar: lookup
    2. Mercer MA, Davis JL, McKenzie HC. The Clinical Pharmacology and Therapeutic Evaluation of Non-Steroidal Anti-Inflammatory Drugs in Adult Horses. Animals (Basel) 2023 May 10;13(10).
      doi: 10.3390/ani13101597pubmed: 37238029google scholar: lookup
    3. Kuroda T, Minamijima Y, Nomura M, Yamashita S, Yamada M, Nagata S, Mita H, Tamura N, Fukuda K, Kuwano A, Kusano K, Toutain PL, Sato F. Medication control of flunixin in racing horses: Possible detection times using Monte Carlo simulations. Equine Vet J 2022 Sep;54(5):979-988.
      doi: 10.1111/evj.13532pubmed: 34719043google scholar: lookup
    4. Smith JS, Marmulak TL, Angelos JA, Lin Z, Rowe JD, Carlson JL, Shelver WL, Lee EA, Tell LA. Pharmacokinetic Parameters and Estimated Milk Withdrawal Intervals for Domestic Goats (Capra Aegagrus Hircus) After Administration of Single and Multiple Intravenous and Subcutaneous Doses of Flunixin Meglumine. Front Vet Sci 2020;7:213.
      doi: 10.3389/fvets.2020.00213pubmed: 32509803google scholar: lookup